Korea to exempt some INDs from approval procedure
This article was originally published in SRA
Executive Summary
Revisions to South Korea’s Pharmaceutical Affairs Law may allow certain investigational new drugs to start clinical trials earlier, says the Korea Food and Drug Administration1. The changes are expected to be implemented within the first quarter of 2009.